Ring-expanded nucleoside analogues. 1,3-Dioxan-5-yl pyrimidines

Journal of Organic Chemistry

Volumn 63, Issue 14, 1998, Pages 4574-4580

  Cadet, Gina ^a   Chan, Ching See ^a   Daniel, Rose Y ^a   Davis, Claudette P ^a   Guiadeen, Deodialsingh ^a   Rodriguez, George ^a   Thomas, Tamara ^a   Walcott, Sean ^a   Scheiner, Peter ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIOXANE DERIVATIVE; NUCLEOSIDE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CANCER; DRUG CONFORMATION; DRUG SYNTHESIS; EPSTEIN BARR VIRUS; HERPES SIMPLEX VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; VIRUS INFECTION;

EID: 0032504137     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo9715231     Document Type: Article

References (64)

1. Norbeck, D.; Spanton, S.; Broder, S.; Mitsuya, H. Tetrahedron Lett. 1989, 30, 6263.
2. (b) Kim, H. O.; Ahn, S. K.; Alves, A. J.; Beach, J. W.; Jeong, L. S.; Choi, B. G.; Van Roey, P.; Schinazi, R. F.; Chu, C. K. J. Med. Chem. 1992, 35, 1987.
3. (c) Kim, H. O.; Schinazi, R. F.; Shanmuganathan, K.; Jeon, L. S.; Beach, J. W.; Nampalli, S.; Cannon, D. L.; Chu, C. K. J. Med. Chem. 1993, 36, 519.
4. Grove, K. L.; Guo, X.; Liu, S.-H.; Gao, Z.; Chu, C. K.; Cheng, Y.-C. Cancer Res. 1995, 55, 3008.
5. (a) Soudens, H.; Yao, X.-J.; Gao, Q.; Belleau, B.; Kraus, J.-L.; Nguyen-Ba,.; Spira, B.; Wainberg, M. A. Antimicrob. Agents Chemother. 1991, 35, 1386.
6. (b) Schinazi, R. F.; Chu, C. K.; Peck, A.; McMillan, A.; Mathis, R.; Cannon, D.; Jeong, L.-S.; Beach, J. W.; Choi, W.-B.; Yeola, S.; Liotta, D. C. Antimicrob. Agents Chemother. 1992, 6, 672.
7. (c) Beach, J. W.; Jeong, L. S.; Alves, A. J.; Pohl, D.; Kim, H. O.; Chang, C.-N.; Doong, S.-L.; Schinazi, R. F.; Cheng, Y.-C.; Chu, C. K. J. Org. Chem. 1992, 57, 2217.
8. (d) Jin, H.; Siddiqui, M. A.; Evans, C. A.; Tse, H. L. A.; Mansour, T.; Goodyear, M. D.; Ravenscroft, P.; Beels, C. D. J. Org. Chem. 1995, 60, 2621 and references therein.
9. (a) Chang, C.-N.; Doong, S.-L.; Zhou, J. H.; Beach, J. W.; Jeong, L.-S.; Chu, C. K.; Tsai, C.-H.; Cheng, Y.-C. J. Biol. Chem. 1992, 267, 13938.
10. (b) Schinazi, R. F.; McMillan, A.; Cannon, D.; Mathis, R.; Lloyd, R. M.; Peck, A.; Sommadossi, J.-P.; St. Clair, M.; Wilson, J.; Furman, P. A.; Painter, G.; Choi, W.-B.; Liotta, D. C. Antimicrob. Agents Chemother. 992, 36, 2423.
11. Herdewijn, P.; Van Aershot, A.; Balzarini, J.; De Clercq, E. In New Methods in Drug Research, Vol. 3; Makriyannis, A., Ed.; Prous Science Publishers: S.A. 1989; Chapter 7, p 1036.
12. (a) Herdewijn, P.; Van Aershot, A. Bull. Soc. Chim. Belg. 1990, 99, 169.
13. (b) Herdewijn, P.; Van Aershot,; Balzarini, J.; De Clercq, E. Nucleosides Nucleotides 1991, 10, 119.
14. (c) Pederson, H.; Pederson, E. B.; Nielsen, C. M. Heterocycles 1992, 34, 265.
15. (a) Ramesh, K.; Wolfe, M. S.; Lee, Y.; Vandervelde, D.; Borchardt, R. T. J. Org. Chem. 1992, 57, 5861.
16. (b) Maurinsh, Y.; Schraml, J.; De Winter, H.; Blaton, N.; Peeters, O.; Lescrinier, E.; Rozenski, J.; Van Aershot, A.; De Clercq, E.; Busson, R.; Herdewijn, P. J. Org. Chem. 1997, 62, 2861.
17. (a) Arango, J. H.; Geer, A.; Rodriguez, J.; Young, P. E.; Scheiner, P. Nucleosides Nucleotides 1993, 12, 773.
18. (b) Reference 7b.
19. (c) Perez-Perez, M.-J.; Rozenski, J.; Busson, R.; Herdewijn, P. J. Org. Chem. 1995, 60, 1531.
20. (d) Konkel, M. J.; Vince, R. Nucleosides Nucleotides 1995, 14, 2061.
21. (a) Verheggen, I.; Van Aershot, A.; Toppet, S.; Snoeck, R.; Janssen, G.; Baizarini, J.; De Clercq, E.; Herdewijn, P. J. Med. Chem. 1993, 36, 2033.
22. (b) Verheggen, I.; Van Aershot, A.; Van Meervelt, L.; Rozenski, J.; Wiebe, L.; Snoeck, R.; Andrei, G. Balzarini, J.; Claes, P.; De Clercq, E.; Herdewijn, P. J. Med. Chem. 1995, 38, 826.
23. (c) Hossain, N.; Rozenski, J.; De Clercq, E.; Herdewijn, P. J. Org. Chem. 1997, 62, 2242.
24. (a) Eliel, E. L. Acc. Chem. Res. 1970, 3, 1.
25. (b) Eliel, E. L. Angew. Chem., Int. Ed. Engl. 1972, 11, 739.
26. (c) Riddell, F. G. The Conformational Analysis of Heterocyclic Compounds: Academic Press: London, 1980.
27. Eliel, E. L.; Knoeber, M. J. Am. Chem. Soc. 1968, 90, 3444.
28. (a) Gelan, J.; Anteunis, M. Bull. Soc. Chim. Belg. 1968, 77, 423.
29. (b) de Kok, A. J.; Romers, C. Recl. Trav. Chim. Pays-Bas 1970, 89, 313.
30. Valeria, M.; Roberts, S. M.; Storer, R.; Bethell, R. J. Chem. Soc., Perkin Trans. 1 1994, 1477.
31. Skalski, V.; Yang, C.-N.; Dutschman, G.; Cheng, Y.-C. J. Biol. Chem. 1993, 268, 23234.
32. (a) Boucher, C. A. B.; Gu, Z.; Gao, Q.; Cammack, N. Antimicrob. Agents Chemother. 1993, 37, 2231.
33. (b) Schinazi, R. F.; Lloyd, R. M.; Nguyen, M. H.; et al. Antimicrob. Agents Chemother. 1993, 37, 875.
34. (c) Gu, Z.; Gao, Q.; Fang, H.; et al. Antimicrob. Agents Chemother. 1994, 38, 275.
35. Van Draanen, N. A.; Tisdale, N.; Parry, N. R.; Jensen, R.; Dornsife, R. A.; Tuttle, J. V.; Averett, D. R.; Koszalka, G. W. Antimicrob. Agents Chemother. 1994, 38, 868.
36. Mikhailov, S. N.; Smrt, J. Collect. Czech. Chem. Commun. 1975, 40, 3080.
37. Cruickshank, K. A.; Jiricny, J.; Reese, C. B. Tetrahedron Lett. 1984, 25, 681.
38. Kametani, T.; Kigasawa, K.; Hiragi, M.; Wakisaka, K.; Haga, S.; Nagamatsu, Y.; Sugi, H.; Fukawa, K.; Irino, O.; Yamamoto, T.; Nishimura, N.; Taguchi, A.; Okada, T.; Nakayama, M. J. Med. Chem. 1980, 23, 1324.
39. This method has also been used to prepare the corresponding 9-adeninyl (78% from unprotected adenine) and 9-guaninyl (33% from 2-amino-6-chloropurine) derivatives of 9.
40. (a) Bronson, J. J.; Ghazzouli, I.; Hitchcock, M. J. M.; Webb, R. R.; Martin, J. C. J. Med. Chem. 1989, 32, 1457.
41. (b) Bonnal, C.; Chavis, C.; Lucas, M. J. Chem. Soc., Perkin Trans. 1 1994, 1401.
42. (c) Rodriguez, J. B.; Marquez, V. E.; Nicklaus, M. C.; Mitsuya, H.; Barchi, J. J. J. Med. Chem. 1994, 37, 3389.
43. (d) Toyota, A.; Katagiri, N.; Kaneko, C. Heterocycles 1993, 36, 1625.
44. Shiao, M.-J.; Yang, C.-Y.; Lee, S.-H.; Wu, T.-C. Synth. Commun. 1988, 18, 359.
45. Riddell, F. G.; Robinson, M. J. T. Tetrahedron 1967, 23, 3417.
46. (a) Eliel, E. L.; Kaloustian, M. K. Chem. Commun. 1970, 290.
47. (b) Eliel, E. L.; Banks, H. D. J. Am. Chem. Soc. 1972, 94, 171.
48. (a) Luttringhaus, A.; Kabuss, S.; Prinzbach, H.; Langenbucher, F. Ann. 1962, 653, 195.
49. (b) Abraham, R. J.; Thomas, W. A. J. Chem. Soc. 1965, 335.
50. Bronson, J. J.; Ferrara, L. M.; Howell, H. G.; Brodfueher, P. R.; Martin, J. C. Nucleosides Nucleotides 1990, 9, 745.
51. Bartlett, P. A.; Green, F. R. J. Am. Chem. Soc. 1978, 100, 4858.
52. Liang, C.; Lee, D. W.; Newton, M. G.; Chu, C. K. J. Org. Chem. 1995, 60, 1546.
53. Lin, T-S.; Luo, M.-Z.; Liu, M.-C.; Clarke-Katzenburg, R. H.; Cheng, Y.-C.; Prusoff, W. H.; Mancini, W. R.; Birnbaum, G. I.; Gabe, E. J.; Giziewicz, J. J. Med. Chem. 1991, 34, 2607.
54. (a) Eliel, E. L.; Hutchins, R. O. J. Am. Chem. Soc. 1969, 91, 2703.
55. (b) Eliel, E. L.; Kandasamy, D.; Sechrest, R. C. J. Org. Chem. 1977, 42, 1533.
56. (c) Kaloustian, M. K.; Dennis, N.; Mager, S.; Evans, S. A.; Alcudia, F.; Eliel, E. L. J. Am. Chem. Soc. 1976, 98, 956.
57. Advanced Chemistry Development, Inc., HNMR 2.5. simultator program.
58. Abraham, R. J.; Banks, H. D.; Eliel, E. L.; Hofer, O.; Kaloustian, M. K. J. Am. Chem. Soc. 1972, 94, 1913.
59. HSV: Bastow, K. F.; Dersem D. D.; Cheng, Y.-C. Antimicrob. Agents Chemother. 1983, 23, 914. EBV: Yao, G.-Q.; Tsai, C.-H.; Cheng, Y.-C. Virus Genes 1995, 9, 247. HIV-1: Mellors, J. W.; Dutschman, G. E.; Im, G.-J.; Tramontano, E.; Winkler, S. R.; Cheng, Y.-C. Mol. Pharmacol. 1992, 41, 446. HBV: Doong, S.-L.; Tsai, C.-H.; Schinazi, R. F.; Liotta, D. C.; Cheng, Y.-C. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 8495.
60. HSV: Bastow, K. F.; Dersem D. D.; Cheng, Y.-C. Antimicrob. Agents Chemother. 1983, 23, 914. EBV: Yao, G.-Q.; Tsai, C.-H.; Cheng, Y.-C. Virus Genes 1995, 9, 247. HIV-1: Mellors, J. W.; Dutschman, G. E.; Im, G.-J.; Tramontano, E.; Winkler, S. R.; Cheng, Y.-C. Mol. Pharmacol. 1992, 41, 446. HBV: Doong, S.-L.; Tsai, C.-H.; Schinazi, R. F.; Liotta, D. C.; Cheng, Y.-C. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 8495.
61. HSV: Bastow, K. F.; Dersem D. D.; Cheng, Y.-C. Antimicrob. Agents Chemother. 1983, 23, 914. EBV: Yao, G.-Q.; Tsai, C.-H.; Cheng, Y.-C. Virus Genes 1995, 9, 247. HIV-1: Mellors, J. W.; Dutschman, G. E.; Im, G.-J.; Tramontano, E.; Winkler, S. R.; Cheng, Y.-C. Mol. Pharmacol. 1992, 41, 446. HBV: Doong, S.-L.; Tsai, C.-H.; Schinazi, R. F.; Liotta, D. C.; Cheng, Y.-C. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 8495.
62. HSV: Bastow, K. F.; Dersem D. D.; Cheng, Y.-C. Antimicrob. Agents Chemother. 1983, 23, 914. EBV: Yao, G.-Q.; Tsai, C.-H.; Cheng, Y.-C. Virus Genes 1995, 9, 247. HIV-1: Mellors, J. W.; Dutschman, G. E.; Im, G.-J.; Tramontano, E.; Winkler, S. R.; Cheng, Y.-C. Mol. Pharmacol. 1992, 41, 446. HBV: Doong, S.-L.; Tsai, C.-H.; Schinazi, R. F.; Liotta, D. C.; Cheng, Y.-C. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 8495.
63. Perez-Perez, M.-J.; De Clercq, E.; Herdewijn, P. Bioorg. Med. Chem. Lett. 1996, 6, 1457.
64. Scheiner, P.; Geer, A.; Buckner, A.-M.; Imbach, J.-L.; Schinazi, R. F. J. Med. Chem. 1989, 32, 73.